Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CA 2268175 C · Owner: Mayo Foundation For Medical Education And Research · Inventors: Kelm, Gary Robert; Kondo, Koji; Nakajima, Akio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a pharmaceutical composition in a unit dosage form for peroral administration in a human or lower animal, having a gastrointestinal tract comprising a small intestine and a colon with a lumen therethrough having an inlet to the colon from the small intestine, comprising: a) a safe and effective amount of a therapeutically active agent incorporated into a compressed bi-convex, tablet, with a maximum diameter of about 4 mm to about 10 mm; b) a non-pH dependent smoothing coat applied to the tablet to provide a smooth tablet surface free from edges or sharp curves; and c) an enteric polymer coating material comprising at least one inner coating layer and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 10, 1997 and granted April 23, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 10, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 10, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.